Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4092682
Max Phase: Preclinical
Molecular Formula: C21H18O4
Molecular Weight: 334.37
Molecule Type: Small molecule
Associated Items:
ID: ALA4092682
Max Phase: Preclinical
Molecular Formula: C21H18O4
Molecular Weight: 334.37
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: C=C1C(=O)Oc2ccccc2[C@H]1[C@@H]1CCc2cc(OC)ccc2C1=O
Standard InChI: InChI=1S/C21H18O4/c1-12-19(16-5-3-4-6-18(16)25-21(12)23)17-9-7-13-11-14(24-2)8-10-15(13)20(17)22/h3-6,8,10-11,17,19H,1,7,9H2,2H3/t17-,19-/m0/s1
Standard InChI Key: SBRDMTHARGOHPS-HKUYNNGSSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 334.37 | Molecular Weight (Monoisotopic): 334.1205 | AlogP: 3.70 | #Rotatable Bonds: 2 |
Polar Surface Area: 52.60 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 0 |
#RO5 Violations: 0 | HBA (Lipinski): 4 | HBD (Lipinski): 0 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: | CX Basic pKa: | CX LogP: 4.17 | CX LogD: 4.17 |
Aromatic Rings: 2 | Heavy Atoms: 25 | QED Weighted: 0.48 | Np Likeness Score: 0.81 |
1. (2016) 7 (9): [10.1039/C6MD00118A] |
Source(1):